Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
66,159.91 -60.70 (-0.09%) CMC Crypto 200
1,374.47 -43.41 (-3.06%)
ACET Jun 2024 2.500 call
| Previous close | 0.0900 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 0.1000 |
| Strike | 2.50 |
| Expiry date | 2024-06-21 |
| Day's range | 0.0500 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 194 |
Simply Wall St.We're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
- Business Wire
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
REDWOOD CITY, Calif. & BOSTON, June 05, 2024--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ADI-001 for the potential treatment of relapsed/refractory class III or class IV lupus nephritis.
Business WireAdicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif. & BOSTON, May 31, 2024--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on May 31, 2024.
